| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Medical Pharmacology and Toxicology, University of California, Davis, CA 95616;
Institute for Biochemical Pharmacology, Medical University Innsbruck, Innsbruck, Austria;
Bachem Bioscience, Inc., King of Prussia, PA 19406; and
Department of Physiology and Biophysics, University of California, Irvine, CA 92697
Using whole-cell patch-clamp, fluorescence microscopy and flow cytometry, we demonstrate a switch in potassium channel expression during differentiation of human B cells from naive to memory cells. Naive and IgD+CD27+ memory B cells express small numbers of the voltage-gated Kv1.3 and the Ca2+-activated intermediate-conductance IKCa1 channel when quiescent, and increase IKCa1 expression 45-fold upon activation with no change in Kv1.3 levels. In contrast, quiescent class-switched memory B cells express high levels of Kv1.3 (
2000 channels/cell) and maintain their Kv1.3high expression after activation. Consistent with their channel phenotypes, proliferation of naive and IgD+CD27+ memory B cells is suppressed by the specific IKCa1 inhibitor TRAM-34 but not by the potent Kv1.3 blocker Stichodactyla helianthus toxin, whereas the proliferation of class-switched memory B cells is suppressed by Stichodactyla helianthus toxin but not TRAM-34. These changes parallel those reported for T cells. Therefore, specific Kv1.3 and IKCa1 inhibitors may have use in therapeutic manipulation of selective lymphocyte subsets in immunological disorders.
This article has been cited by other articles:
|
|
 |
|
  H. Zheng, J. H. Nam, B. Pang, D. H. Shin, J. S. Kim, Y.-S. Chun, J.-W. Park, H. Bang, W. K. Kim, Y. E. Earm, et al. Identification of the large-conductance background K+ channel in mouse B cells as TREK-2 Am J Physiol Cell Physiol, July 1, 2009; 297(1): C188 - C197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Lee, Y. Hasegawa, T. Shimizu, and Y. Okada IK1 channel activity contributes to cisplatin sensitivity of human epidermoid cancer cells Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1398 - C1406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Pereira, F. Villinger, H. Wulff, A. Sankaranarayanan, G. Raman, and A. A. Ansari Pharmacokinetics, Toxicity, and Functional Studies of the Selective Kv1.3 Channel Blocker 5-(4-Phenoxybutoxy)Psoralen in Rhesus Macaques Experimental Biology and Medicine, November 1, 2007; 232(10): 1338 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Nicolaou, P. Szigligeti, L. Neumeier, S. Molleran Lee, H. J. Duncan, S. K. Kant, A. B. Mongey, A. H. Filipovich, and L. Conforti Altered Dynamics of Kv1.3 Channel Compartmentalization in the Immunological Synapse in Systemic Lupus Erythematosus J. Immunol., July 1, 2007; 179(1): 346 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Cruse, S M Duffy, C E Brightling, and P Bradding Functional KCa3.1 K+ channels are required for human lung mast cell migration Thorax, October 1, 2006; 61(10): 880 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Srivastava, K. Ko, P. Choudhury, Z. Li, A. K. Johnson, V. Nadkarni, D. Unutmaz, W. A. Coetzee, and E. Y. Skolnik Phosphatidylinositol-3 Phosphatase Myotubularin-Related Protein 6 Negatively Regulates CD4 T Cells Mol. Cell. Biol., August 1, 2006; 26(15): 5595 - 5602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mouhat, G. Teodorescu, D. Homerick, V. Visan, H. Wulff, Y. Wu, S. Grissmer, H. Darbon, M. De Waard, and J.-M. Sabatier Pharmacological Profiling of Orthochirus scrobiculosus Toxin 1 Analogs with a Trimmed N-Terminal Domain Mol. Pharmacol., January 1, 2006; 69(1): 354 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Srivastava, P. Choudhury, Z. Li, G. Liu, V. Nadkarni, K. Ko, W. A. Coetzee, and E. Y. Skolnik Phosphatidylinositol 3-Phosphate Indirectly Activates KCa3.1 via 14 Amino Acids in the Carboxy Terminus of KCa3.1 Mol. Biol. Cell, January 1, 2006; 17(1): 146 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Beeton and K. G. Chandy Potassium Channels, Memory T Cells, and Multiple Sclerosis Neuroscientist, December 1, 2005; 11(6): 550 - 562. [Abstract] [PDF]
|
|
|
|
|
|
A. Schmitz, A. Sankaranarayanan, P. Azam, K. Schmidt-Lassen, D. Homerick, W. Hansel, and H. Wulff Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases Mol. Pharmacol., November 1, 2005; 68(5): 1254 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dreker and S. Grissmer Investigation of the Phenylalkylamine Binding Site in hKv1.3 (H399T), a Mutant with a Reduced C-Type Inactivated State Mol. Pharmacol., October 1, 2005; 68(4): 966 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Rus, C. A. Pardo, L. Hu, E. Darrah, C. Cudrici, T. Niculescu, F. Niculescu, K. M. Mullen, R. Allie, L. Guo, et al. The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain PNAS, August 2, 2005; 102(31): 11094 - 11099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Valverde, T. Kawai, and M.A. Taubman Potassium Channel-blockers as Therapeutic Agents to Interfere with Bone Resorption of Periodontal Disease Journal of Dental Research, June 1, 2005; 84(6): 488 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Srivastava, Z. Li, L. Lin, G. Liu, K. Ko, W. A. Coetzee, and E. Y. Skolnik The Phosphatidylinositol 3-Phosphate Phosphatase Myotubularin- Related Protein 6 (MTMR6) Is a Negative Regulator of the Ca2+-Activated K+ Channel KCa3.1 Mol. Cell. Biol., May 1, 2005; 25(9): 3630 - 3638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Beeton, M. W. Pennington, H. Wulff, S. Singh, D. Nugent, G. Crossley, I. Khaytin, P. A. Calabresi, C.-Y. Chen, G. A. Gutman, et al. Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases Mol. Pharmacol., April 1, 2005; 67(4): 1369 - 1381. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
